mda mb 436 cells Search Results


90
CLS Cell Lines Service GmbH mda mb 436 cells
Mda Mb 436 Cells, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mda mb 436 cells/product/CLS Cell Lines Service GmbH
Average 90 stars, based on 1 article reviews
mda mb 436 cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Corning Life Sciences mda-mb-231 cells (1×10 4 )
NRSN2 knockdown suppresses and NRSN2 overexpression increases the proliferation of breast cancer cells in vitro . (A) NRSN2 knockdown decreased NRSN2 expression in <t>MDA-MB-231</t> cells. (B) NRSN2 overexpression increased NRSN2 expression in MDA-MB-231 cells. (C) NRSN2 knockdown inhibited MDA-MB-231 cell proliferation. (D) NRSN2 overexpression promoted MDA-MB-231 cell proliferation. (E) NRSN2 knockdown inhibited the colony formation of MDA-MB-231 cells. (F) NRSN2 overexpression promoted the colony formation of MDA-MB-231 cells. NC, negative control; NRSN2, neurensin-2; ns, not significant; si, small interfering (RNA); siR-NRSN2, siRNA against NRSN2; pRK5-NRSN2, NRSN2 overexpression vector. **P<0.01.
Mda Mb 231 Cells (1×10 4 ), supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mda-mb-231 cells (1×10 4 )/product/Corning Life Sciences
Average 90 stars, based on 1 article reviews
mda-mb-231 cells (1×10 4 ) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Erytech Inc mda-mb-436 tnbc cell line
NRSN2 knockdown suppresses and NRSN2 overexpression increases the proliferation of breast cancer cells in vitro . (A) NRSN2 knockdown decreased NRSN2 expression in <t>MDA-MB-231</t> cells. (B) NRSN2 overexpression increased NRSN2 expression in MDA-MB-231 cells. (C) NRSN2 knockdown inhibited MDA-MB-231 cell proliferation. (D) NRSN2 overexpression promoted MDA-MB-231 cell proliferation. (E) NRSN2 knockdown inhibited the colony formation of MDA-MB-231 cells. (F) NRSN2 overexpression promoted the colony formation of MDA-MB-231 cells. NC, negative control; NRSN2, neurensin-2; ns, not significant; si, small interfering (RNA); siR-NRSN2, siRNA against NRSN2; pRK5-NRSN2, NRSN2 overexpression vector. **P<0.01.
Mda Mb 436 Tnbc Cell Line, supplied by Erytech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mda-mb-436 tnbc cell line/product/Erytech Inc
Average 90 stars, based on 1 article reviews
mda-mb-436 tnbc cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Northport Systems Inc emmprin-transfected mda-mb-436 cells
NRSN2 knockdown suppresses and NRSN2 overexpression increases the proliferation of breast cancer cells in vitro . (A) NRSN2 knockdown decreased NRSN2 expression in <t>MDA-MB-231</t> cells. (B) NRSN2 overexpression increased NRSN2 expression in MDA-MB-231 cells. (C) NRSN2 knockdown inhibited MDA-MB-231 cell proliferation. (D) NRSN2 overexpression promoted MDA-MB-231 cell proliferation. (E) NRSN2 knockdown inhibited the colony formation of MDA-MB-231 cells. (F) NRSN2 overexpression promoted the colony formation of MDA-MB-231 cells. NC, negative control; NRSN2, neurensin-2; ns, not significant; si, small interfering (RNA); siR-NRSN2, siRNA against NRSN2; pRK5-NRSN2, NRSN2 overexpression vector. **P<0.01.
Emmprin Transfected Mda Mb 436 Cells, supplied by Northport Systems Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/emmprin-transfected mda-mb-436 cells/product/Northport Systems Inc
Average 90 stars, based on 1 article reviews
emmprin-transfected mda-mb-436 cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Crown Bioscience mda-mb-436 human cell line-derived breast cancer model
NRSN2 knockdown suppresses and NRSN2 overexpression increases the proliferation of breast cancer cells in vitro . (A) NRSN2 knockdown decreased NRSN2 expression in <t>MDA-MB-231</t> cells. (B) NRSN2 overexpression increased NRSN2 expression in MDA-MB-231 cells. (C) NRSN2 knockdown inhibited MDA-MB-231 cell proliferation. (D) NRSN2 overexpression promoted MDA-MB-231 cell proliferation. (E) NRSN2 knockdown inhibited the colony formation of MDA-MB-231 cells. (F) NRSN2 overexpression promoted the colony formation of MDA-MB-231 cells. NC, negative control; NRSN2, neurensin-2; ns, not significant; si, small interfering (RNA); siR-NRSN2, siRNA against NRSN2; pRK5-NRSN2, NRSN2 overexpression vector. **P<0.01.
Mda Mb 436 Human Cell Line Derived Breast Cancer Model, supplied by Crown Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mda-mb-436 human cell line-derived breast cancer model/product/Crown Bioscience
Average 90 stars, based on 1 article reviews
mda-mb-436 human cell line-derived breast cancer model - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Procell Inc cell line mda-mb-436
NRSN2 knockdown suppresses and NRSN2 overexpression increases the proliferation of breast cancer cells in vitro . (A) NRSN2 knockdown decreased NRSN2 expression in <t>MDA-MB-231</t> cells. (B) NRSN2 overexpression increased NRSN2 expression in MDA-MB-231 cells. (C) NRSN2 knockdown inhibited MDA-MB-231 cell proliferation. (D) NRSN2 overexpression promoted MDA-MB-231 cell proliferation. (E) NRSN2 knockdown inhibited the colony formation of MDA-MB-231 cells. (F) NRSN2 overexpression promoted the colony formation of MDA-MB-231 cells. NC, negative control; NRSN2, neurensin-2; ns, not significant; si, small interfering (RNA); siR-NRSN2, siRNA against NRSN2; pRK5-NRSN2, NRSN2 overexpression vector. **P<0.01.
Cell Line Mda Mb 436, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell line mda-mb-436/product/Procell Inc
Average 90 stars, based on 1 article reviews
cell line mda-mb-436 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Korean Cell Line Bank mda-mb-436
NRSN2 knockdown suppresses and NRSN2 overexpression increases the proliferation of breast cancer cells in vitro . (A) NRSN2 knockdown decreased NRSN2 expression in <t>MDA-MB-231</t> cells. (B) NRSN2 overexpression increased NRSN2 expression in MDA-MB-231 cells. (C) NRSN2 knockdown inhibited MDA-MB-231 cell proliferation. (D) NRSN2 overexpression promoted MDA-MB-231 cell proliferation. (E) NRSN2 knockdown inhibited the colony formation of MDA-MB-231 cells. (F) NRSN2 overexpression promoted the colony formation of MDA-MB-231 cells. NC, negative control; NRSN2, neurensin-2; ns, not significant; si, small interfering (RNA); siR-NRSN2, siRNA against NRSN2; pRK5-NRSN2, NRSN2 overexpression vector. **P<0.01.
Mda Mb 436, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mda-mb-436/product/Korean Cell Line Bank
Average 90 stars, based on 1 article reviews
mda-mb-436 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Jackson Laboratory mda-mb-436 cells
NRSN2 knockdown suppresses and NRSN2 overexpression increases the proliferation of breast cancer cells in vitro . (A) NRSN2 knockdown decreased NRSN2 expression in <t>MDA-MB-231</t> cells. (B) NRSN2 overexpression increased NRSN2 expression in MDA-MB-231 cells. (C) NRSN2 knockdown inhibited MDA-MB-231 cell proliferation. (D) NRSN2 overexpression promoted MDA-MB-231 cell proliferation. (E) NRSN2 knockdown inhibited the colony formation of MDA-MB-231 cells. (F) NRSN2 overexpression promoted the colony formation of MDA-MB-231 cells. NC, negative control; NRSN2, neurensin-2; ns, not significant; si, small interfering (RNA); siR-NRSN2, siRNA against NRSN2; pRK5-NRSN2, NRSN2 overexpression vector. **P<0.01.
Mda Mb 436 Cells, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mda-mb-436 cells/product/Jackson Laboratory
Average 90 stars, based on 1 article reviews
mda-mb-436 cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Keimling Naturkost mda-mb-436 cells
NRSN2 knockdown suppresses and NRSN2 overexpression increases the proliferation of breast cancer cells in vitro . (A) NRSN2 knockdown decreased NRSN2 expression in <t>MDA-MB-231</t> cells. (B) NRSN2 overexpression increased NRSN2 expression in MDA-MB-231 cells. (C) NRSN2 knockdown inhibited MDA-MB-231 cell proliferation. (D) NRSN2 overexpression promoted MDA-MB-231 cell proliferation. (E) NRSN2 knockdown inhibited the colony formation of MDA-MB-231 cells. (F) NRSN2 overexpression promoted the colony formation of MDA-MB-231 cells. NC, negative control; NRSN2, neurensin-2; ns, not significant; si, small interfering (RNA); siR-NRSN2, siRNA against NRSN2; pRK5-NRSN2, NRSN2 overexpression vector. **P<0.01.
Mda Mb 436 Cells, supplied by Keimling Naturkost, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mda-mb-436 cells/product/Keimling Naturkost
Average 90 stars, based on 1 article reviews
mda-mb-436 cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


NRSN2 knockdown suppresses and NRSN2 overexpression increases the proliferation of breast cancer cells in vitro . (A) NRSN2 knockdown decreased NRSN2 expression in MDA-MB-231 cells. (B) NRSN2 overexpression increased NRSN2 expression in MDA-MB-231 cells. (C) NRSN2 knockdown inhibited MDA-MB-231 cell proliferation. (D) NRSN2 overexpression promoted MDA-MB-231 cell proliferation. (E) NRSN2 knockdown inhibited the colony formation of MDA-MB-231 cells. (F) NRSN2 overexpression promoted the colony formation of MDA-MB-231 cells. NC, negative control; NRSN2, neurensin-2; ns, not significant; si, small interfering (RNA); siR-NRSN2, siRNA against NRSN2; pRK5-NRSN2, NRSN2 overexpression vector. **P<0.01.

Journal: Oncology Letters

Article Title: NRSN2 promotes breast cancer metastasis by activating PI3K/AKT/mTOR and NF-κB signaling pathways

doi: 10.3892/ol.2019.11152

Figure Lengend Snippet: NRSN2 knockdown suppresses and NRSN2 overexpression increases the proliferation of breast cancer cells in vitro . (A) NRSN2 knockdown decreased NRSN2 expression in MDA-MB-231 cells. (B) NRSN2 overexpression increased NRSN2 expression in MDA-MB-231 cells. (C) NRSN2 knockdown inhibited MDA-MB-231 cell proliferation. (D) NRSN2 overexpression promoted MDA-MB-231 cell proliferation. (E) NRSN2 knockdown inhibited the colony formation of MDA-MB-231 cells. (F) NRSN2 overexpression promoted the colony formation of MDA-MB-231 cells. NC, negative control; NRSN2, neurensin-2; ns, not significant; si, small interfering (RNA); siR-NRSN2, siRNA against NRSN2; pRK5-NRSN2, NRSN2 overexpression vector. **P<0.01.

Article Snippet: MDA-MB-231 cells (1×10 4 ) were seeded in 6-well plates (Corning Inc.) and transiently transfected with pRK5-hNRSN2 (2 µg) or pRK5-control (pControl) (2 µg) using Lipofectamine ® 2000 (cat. no. 11668-027; Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol.

Techniques: Over Expression, In Vitro, Expressing, Negative Control, Small Interfering RNA, Plasmid Preparation

NRSN2 promotes tumor cell migration and invasion in vitro . NRSN2 overexpression promoted the (A) migration and (B) invasion of MDA-MB-231 cells. NRSN2 knockdown inhibited the (C) migration and (D) invasion of MDA-MB-231 cells. NRSN2, neurensin-2; si, small interfering (RNA); siR-NRSN2, siRNA against NRSN2; pRK5-NRSN2, NRSN2 overexpression vector. **P<0.01.

Journal: Oncology Letters

Article Title: NRSN2 promotes breast cancer metastasis by activating PI3K/AKT/mTOR and NF-κB signaling pathways

doi: 10.3892/ol.2019.11152

Figure Lengend Snippet: NRSN2 promotes tumor cell migration and invasion in vitro . NRSN2 overexpression promoted the (A) migration and (B) invasion of MDA-MB-231 cells. NRSN2 knockdown inhibited the (C) migration and (D) invasion of MDA-MB-231 cells. NRSN2, neurensin-2; si, small interfering (RNA); siR-NRSN2, siRNA against NRSN2; pRK5-NRSN2, NRSN2 overexpression vector. **P<0.01.

Article Snippet: MDA-MB-231 cells (1×10 4 ) were seeded in 6-well plates (Corning Inc.) and transiently transfected with pRK5-hNRSN2 (2 µg) or pRK5-control (pControl) (2 µg) using Lipofectamine ® 2000 (cat. no. 11668-027; Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol.

Techniques: Migration, In Vitro, Over Expression, Small Interfering RNA, Plasmid Preparation

NRSN2 promotes proliferation, migration and invasion of breast cancer cells by activating PI3K/AKT/mTOR and NF-κB signaling pathways. (A) NRSN2 knockdown significantly inhibited the phosphorylation of PI3K, AKT and mTOR in MDA-MB-231 cells. (B) NRSN2 knockdown significantly decreased the levels of IκBα and P65 phosphorylation in MDA-MB-231 cells. Control, PBS-treated cells. NC, negative control; NRSN2, neurensin-2; ns, not significant; p-, phosphorylated; si, small interfering (RNA); si-RNRSN2, siRNA against NRSN2; pRK5-NRSN2, NRSN2 overexpression vector; NF-κBIR, NF-κB inhibitor; PI3KIR, PI3K inhibitor. **P<0.01. NRSN2 promotes proliferation, migration and invasion of breast cancer cells by activating PI3K/AKT/mTOR and NF-κB signaling pathways. (C) NRSN2 overexpression promoted the phosphorylation of PI3K, AKT and mTOR in MDA-MB-231 cells. (D) NRSN2 overexpression promoted the levels of p-IκBα and p-P65 in MDA-MB-231 cells. Control, PBS-treated cells. NC, negative control; NRSN2, neurensin-2; ns, not significant; p-, phosphorylated; si, small interfering (RNA); si-RNRSN2, siRNA against NRSN2; pRK5-NRSN2, NRSN2 overexpression vector; NF-κBIR, NF-κB inhibitor; PI3KIR, PI3K inhibitor. **P<0.01. NRSN2 promotes proliferation, migration and invasion of breast cancer cells by activating PI3K/AKT/mTOR and NF-κB signaling pathways. (E) NF-κBIR inhibited the pro-proliferation effects of NRSN2 in MDA-MB-231 cells. NF-κBIR suppressed the migration (F) and invasion (G) of MDA-MB-231 cells. PI3KIR suppressed NRSN2-promoted (H) proliferation, (I) migration and (J) invasion of MDA-MB-231 cells. Control, PBS-treated cells. NC, negative control; NRSN2, neurensin-2; ns, not significant; p-, phosphorylated; si, small interfering (RNA); si-RNRSN2, siRNA against NRSN2; pRK5-NRSN2, NRSN2 overexpression vector; NF-κBIR, NF-κB inhibitor; PI3KIR, PI3K inhibitor. **P<0.01.

Journal: Oncology Letters

Article Title: NRSN2 promotes breast cancer metastasis by activating PI3K/AKT/mTOR and NF-κB signaling pathways

doi: 10.3892/ol.2019.11152

Figure Lengend Snippet: NRSN2 promotes proliferation, migration and invasion of breast cancer cells by activating PI3K/AKT/mTOR and NF-κB signaling pathways. (A) NRSN2 knockdown significantly inhibited the phosphorylation of PI3K, AKT and mTOR in MDA-MB-231 cells. (B) NRSN2 knockdown significantly decreased the levels of IκBα and P65 phosphorylation in MDA-MB-231 cells. Control, PBS-treated cells. NC, negative control; NRSN2, neurensin-2; ns, not significant; p-, phosphorylated; si, small interfering (RNA); si-RNRSN2, siRNA against NRSN2; pRK5-NRSN2, NRSN2 overexpression vector; NF-κBIR, NF-κB inhibitor; PI3KIR, PI3K inhibitor. **P<0.01. NRSN2 promotes proliferation, migration and invasion of breast cancer cells by activating PI3K/AKT/mTOR and NF-κB signaling pathways. (C) NRSN2 overexpression promoted the phosphorylation of PI3K, AKT and mTOR in MDA-MB-231 cells. (D) NRSN2 overexpression promoted the levels of p-IκBα and p-P65 in MDA-MB-231 cells. Control, PBS-treated cells. NC, negative control; NRSN2, neurensin-2; ns, not significant; p-, phosphorylated; si, small interfering (RNA); si-RNRSN2, siRNA against NRSN2; pRK5-NRSN2, NRSN2 overexpression vector; NF-κBIR, NF-κB inhibitor; PI3KIR, PI3K inhibitor. **P<0.01. NRSN2 promotes proliferation, migration and invasion of breast cancer cells by activating PI3K/AKT/mTOR and NF-κB signaling pathways. (E) NF-κBIR inhibited the pro-proliferation effects of NRSN2 in MDA-MB-231 cells. NF-κBIR suppressed the migration (F) and invasion (G) of MDA-MB-231 cells. PI3KIR suppressed NRSN2-promoted (H) proliferation, (I) migration and (J) invasion of MDA-MB-231 cells. Control, PBS-treated cells. NC, negative control; NRSN2, neurensin-2; ns, not significant; p-, phosphorylated; si, small interfering (RNA); si-RNRSN2, siRNA against NRSN2; pRK5-NRSN2, NRSN2 overexpression vector; NF-κBIR, NF-κB inhibitor; PI3KIR, PI3K inhibitor. **P<0.01.

Article Snippet: MDA-MB-231 cells (1×10 4 ) were seeded in 6-well plates (Corning Inc.) and transiently transfected with pRK5-hNRSN2 (2 µg) or pRK5-control (pControl) (2 µg) using Lipofectamine ® 2000 (cat. no. 11668-027; Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol.

Techniques: Migration, Negative Control, Small Interfering RNA, Over Expression, Plasmid Preparation